Aastrom Biosciences Inc (ASTM.O)
ASTM.O on Consolidated Issue listed on NASDAQ Capital Market
0.44USD
1 Aug 2013
0.44USD
1 Aug 2013
Price Change (% chg)
$0.03 (+6.62%)
$0.03 (+6.62%)
Prev Close
$0.41
$0.41
Open
$0.42
$0.42
Day's High
$0.45
$0.45
Day's Low
$0.40
$0.40
Volume
718,865
718,865
Avg. Vol
273,886
273,886
52-wk High
$2.00
$2.00
52-wk Low
$0.33
$0.33
About
Aastrom Biosciences, Inc. (Aastrom) is a development-stage company. The Company is a regenerative medicine company focused on the development of cell therapies to repair or regenerate damaged or diseased tissues. The Company is developing patient-specific, expanded multicellular therapies for use in the treatment of severe,... (more)
Overall
| Beta: | 0.06 |
| Market Cap (Mil.): | $18.63 |
| Shares Outstanding (Mil.): | 45.66 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ASTM.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 37.93 | 37.76 |
| EPS (TTM): | -0.72 | -- | -- |
| ROI: | -225.99 | 19.48 | 18.76 |
| ROE: | -- | 20.17 | 19.59 |
Aastrom Biosciences ends drug trial, to cut half its workforce
- Aastrom Biosciences Inc said it would end the late-stage trial of its drug to treat critical limb ischemia (CLI), a form of peripheral arterial disease, and cut about half of its workforce, driving its shares to an all-time low.
Aastrom Biosciences ends drug trial, to cut half its workforce
March 27 - Aastrom Biosciences Inc said it would end the late-stage trial of its drug to treat critical limb ischemia - a form of peripheral arterial disease - and cut about half of its workforce.
Competitors
| Price | Change | |
|---|---|---|
| Terumo Corp (4543.T) | ¥5,100 | +135.00 |
| Johnson & Johnson (JNJ.N) | $93.77 | +0.27 |
| Medtronic, Inc. (MDT.N) | $55.49 | +0.25 |
| Baxter International Inc. (BAX.N) | $72.20 | -0.84 |
| Mesoblast limited (MSB.AX) | $5.86 | -0.01 |
| Cytori Therapeutics Inc. (USA) (CYTX.OQ) | $2.81 | -0.01 |
| NeoStem Inc (NBS.A) | $6.80 | -0.25 |
| Osiris Therapeutics, Inc. (OSIR.OQ) | $11.39 | -0.06 |
| Cytomedix, Inc. (CMXI.OB) | $0.49 | +0.03 |
| Athersys, Inc. (ATHX.OQ) | $1.60 | +0.07 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$58.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

